BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30177394)

  • 21. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of inhibitor of apoptosis‑stimulating protein of p53 inhibits proliferation and promotes apoptosis of gastric cancer cells.
    Wang LL; Xu Z; Peng Y; Li LC; Wu XL
    Mol Med Rep; 2015 Aug; 12(2):1653-8. PubMed ID: 25846425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
    Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
    Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
    Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
    Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
    Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GNA13 as a prognostic factor and mediator of gastric cancer progression.
    Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
    Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
    Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG
    Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
    Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
    Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of CDC42 on the proliferation and invasion of gastric cancer cells.
    Du DS; Yang XZ; Wang Q; Dai WJ; Kuai WX; Liu YL; Chu D; Tang XJ
    Mol Med Rep; 2016 Jan; 13(1):550-4. PubMed ID: 26549550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
    Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
    Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
    Tao Y; Sun C; Zhang T; Song Y
    Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.
    Hu J; Huang Y; Wu Y; Liu F; Sun D; Wang K; Qu H
    Tumour Biol; 2016 Nov; 37(11):15115-15123. PubMed ID: 27662840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis.
    Lv Y; Song Y; Ni C; Wang S; Chen Z; Shi X; Jiang Q; Cao C; Zuo Y
    Cell Physiol Biochem; 2018; 45(3):1219-1229. PubMed ID: 29448250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
    Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
    Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W
    Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of miR-647 in human gastric cancer suppression.
    Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
    Oncol Rep; 2017 Mar; 37(3):1401-1411. PubMed ID: 28098914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.